Zanubrutinib Plus BR in Newly Diagnosed Symptomatic WM
Condition: Waldenstrom Macroglobulinemia Intervention: Drug: Zanubrutinib, Bendamustine and Rituximab Sponsor: Institute of Hematology & Blood Diseases Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials